Literature DB >> 2397183

Oxandrolone for delayed puberty in boys taking long-term steroid therapy for renal disease.

L Rees1, S A Greene, S P Rigden, G B Haycock, C Chantler, M A Preece.   

Abstract

Eleven boys, mean age 15.3 years (range 13.2-17.5), with pubertal delay in association with steroid therapy for steroid-sensitive nephrotic syndrome and following renal transplantation were treated with oxandrolone 2.5 mg daily for a mean of 0.50 years (range 0.34-0.61). Mean growth velocity increased from 3.9 cm/year (range 1.1-6.3) to 6.1 cm/year (range 2.0-14.4) and was maintained at 6.1 cm/year (range 0.4-10.2) (P less than 0.05). However, there was no significant difference in growth between the treated boys and age- and puberty-matched controls. Elevation of blood cyclosporin A and creatinine levels occurred in the transplant patients. Oxandrolone may initiate a pubertal growth spurt in patients taking steroid therapy for renal disease, but should be used with extreme caution because of potential side-effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2397183     DOI: 10.1007/bf00858829

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  6 in total

1.  Growth and endocrine function after renal transplantation.

Authors:  L Rees; S A Greene; P Adlard; J Jones; G B Haycock; S P Rigden; M Preece; C Chantler
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

2.  Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.

Authors:  J M Tanner; R H Whitehouse
Journal:  Arch Dis Child       Date:  1976-03       Impact factor: 3.791

3.  Evaluation of a height/plasma creatinine formula in the measurement of glomerular filtration rate.

Authors:  M C Morris; C W Allanby; P Toseland; G B Haycock; C Chantler
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

4.  Growth and endocrine function in steroid sensitive nephrotic syndrome.

Authors:  L Rees; S A Greene; P Adlard; J Jones; G B Haycock; S P Rigden; M Preece; C Chantler
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

5.  The effects of anabolic steroids on growth, body composition, and metabolism in boys with chronic renal failure on regular hemodialysis.

Authors:  R W Jones; M M El Bishti; S R Bloom; J Burke; J E Carter; R Counahan; R N Dalton; M C Morris; C Chantler
Journal:  J Pediatr       Date:  1980-10       Impact factor: 4.406

6.  Double blind placebo controlled trial of low dose oxandrolone in the treatment of boys with constitutional delay of growth and puberty.

Authors:  R Stanhope; C R Buchanan; G C Fenn; M A Preece
Journal:  Arch Dis Child       Date:  1988-05       Impact factor: 3.791

  6 in total
  2 in total

1.  What investigations are appropriate in a teenage girl with chronic renal failure who has primary amenorrhea?

Authors:  R W Chesney; S Burstein
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

2.  The influence of steroid therapy and recombinant human erythropoietin on the growth of children with renal disease.

Authors:  L Rees; S P Rigden; C Chantler
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.